COVID-19 therapeutic drugs may be slow to arrive
Scientists are exploring over 500 agents that could serve as therapeutics for COVID-19 patients
You must be signed in to read this analysis
In this article
- Investigational drugs
- Current options and progress
- Antivirals
- Monoclonal antibodies
- Immune-modulators and others
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.
